Publications | SONG LABhttps://playful-bavarois-78840e.netlify.app/publication/PublicationsHugo Blox Builder (https://hugoblox.com)en-ushttps://playful-bavarois-78840e.netlify.app/media/logo_hu11652092127514912302.pngPublicationshttps://playful-bavarois-78840e.netlify.app/publication/Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistancehttps://playful-bavarois-78840e.netlify.app/publication/cysltr1-tumor-promoting-myelopoiesis/Sat, 01 Aug 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/cysltr1-tumor-promoting-myelopoiesis/iPSC-Derived Microglia-like Cells Exhibit Protocol-Dependent Transcriptomic Features and Robust Phagocytosis of Glioma Cellshttps://playful-bavarois-78840e.netlify.app/publication/ipsc-microglia-glioma-phagocytosis/Wed, 22 Jul 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/ipsc-microglia-glioma-phagocytosis/Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq Datahttps://playful-bavarois-78840e.netlify.app/publication/stepwise-protocol-alternative-splicing-single-cell-smartseq2/Mon, 01 Jun 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/stepwise-protocol-alternative-splicing-single-cell-smartseq2/An EGFR Co-Amplified and De Novo Long Noncoding RNA HELDR Promotes Glioblastoma Malignancy through KAT7-Driven Gene Programshttps://playful-bavarois-78840e.netlify.app/publication/egfr-heldr-kat7-glioblastoma/Fri, 01 May 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/egfr-heldr-kat7-glioblastoma/Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced QKI isoformshttps://playful-bavarois-78840e.netlify.app/publication/qki-alternative-splicing-glioblastoma/Fri, 01 May 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/qki-alternative-splicing-glioblastoma/Cysteine addiction in drug resistant glioblastoma and therapeutic targeting with designer selenium compoundshttps://playful-bavarois-78840e.netlify.app/publication/cysteine-addiction-glioblastoma-selenium/Sun, 01 Mar 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/cysteine-addiction-glioblastoma-selenium/YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomashttps://playful-bavarois-78840e.netlify.app/publication/ybx1-ybx3-immune-checkpoint-glioma/Thu, 01 Jan 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/ybx1-ybx3-immune-checkpoint-glioma/A Single-Cell Atlas of RNA Alternative Splicing in the Glioma-Immune Ecosystemhttps://playful-bavarois-78840e.netlify.app/publication/single-cell-atlas-rna-alternative-splicing-glioma-immune-ecosystem/Fri, 12 Dec 2025 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/single-cell-atlas-rna-alternative-splicing-glioma-immune-ecosystem/Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancerhttps://playful-bavarois-78840e.netlify.app/publication/circtnk2-tamoxifen-nk-immunity/Mon, 01 Sep 2025 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/circtnk2-tamoxifen-nk-immunity/Targeting PDGFRA-SHP2 Signaling Enhances Radiotherapy in IDH1-Mutant Gliomahttps://playful-bavarois-78840e.netlify.app/publication/pdgfra-shp2-radiotherapy-glioma/Fri, 01 Aug 2025 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/pdgfra-shp2-radiotherapy-glioma/4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor responsehttps://playful-bavarois-78840e.netlify.app/publication/4-1bb-a2b-cd8-tumor-response/Mon, 02 Jun 2025 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/4-1bb-a2b-cd8-tumor-response/Steering research on mRNA splicing in cancer towards clinical translationhttps://playful-bavarois-78840e.netlify.app/publication/mrna-splicing-cancer-clinical-translation/Sun, 01 Dec 2024 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/mrna-splicing-cancer-clinical-translation/RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult gliomahttps://playful-bavarois-78840e.netlify.app/publication/rna-splicing-developmental-hierarchies-adult-glioma/Mon, 03 Jun 2024 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/rna-splicing-developmental-hierarchies-adult-glioma/Toroidal-spiral particles as a CAR-T cell delivery device for solid tumor immunotherapyhttps://playful-bavarois-78840e.netlify.app/publication/toroidal-spiral-particles-car-t/Sun, 01 Oct 2023 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/toroidal-spiral-particles-car-t/Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesishttps://playful-bavarois-78840e.netlify.app/publication/linc02283-pdgfra-glioblastoma/Tue, 05 Sep 2023 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/linc02283-pdgfra-glioblastoma/Repurposing Clemastine to Target Glioblastoma Cell Stemnesshttps://playful-bavarois-78840e.netlify.app/publication/clemastine-glioblastoma-stemness/Fri, 01 Sep 2023 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/clemastine-glioblastoma-stemness/Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosishttps://playful-bavarois-78840e.netlify.app/publication/grade4-glioma-transcriptomic-epigenetic-heterogeneity/Mon, 14 Aug 2023 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/grade4-glioma-transcriptomic-epigenetic-heterogeneity/The Role of Non-Coding RNAs in Gliomahttps://playful-bavarois-78840e.netlify.app/publication/noncoding-rnas-glioma/Sat, 20 Aug 2022 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/noncoding-rnas-glioma/Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomashttps://playful-bavarois-78840e.netlify.app/publication/temozolomide-guanine-vulnerabilities-glioma/Fri, 24 Jun 2022 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/temozolomide-guanine-vulnerabilities-glioma/Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progressionhttps://playful-bavarois-78840e.netlify.app/publication/unconventional-protein-secretion-brain-tumors/Wed, 15 Jun 2022 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/unconventional-protein-secretion-brain-tumors/The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastomahttps://playful-bavarois-78840e.netlify.app/publication/therapy-resistance-tumor-recurrence-glioblastoma/Wed, 24 Feb 2021 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/therapy-resistance-tumor-recurrence-glioblastoma/PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cellshttps://playful-bavarois-78840e.netlify.app/publication/prmt6-rcc1-glioblastoma-stem-cells/Fri, 01 Jan 2021 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/prmt6-rcc1-glioblastoma-stem-cells/LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancementhttps://playful-bavarois-78840e.netlify.app/publication/ly6k-glioblastoma-cav1-erk/Tue, 01 Sep 2020 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/ly6k-glioblastoma-cav1-erk/Stem cell programs in cancer initiation, progression, and therapy resistancehttps://playful-bavarois-78840e.netlify.app/publication/stem-cell-programs-cancer/Wed, 01 Jul 2020 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/stem-cell-programs-cancer/SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processeshttps://playful-bavarois-78840e.netlify.app/publication/srsf3-rna-splicing-glioblastoma/Thu, 01 Aug 2019 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/srsf3-rna-splicing-glioblastoma/MIR93 (microRNA-93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagyhttps://playful-bavarois-78840e.netlify.app/publication/mir93-glioblastoma-autophagy/Tue, 01 Jan 2019 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/mir93-glioblastoma-autophagy/Cancer-testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironmenthttps://playful-bavarois-78840e.netlify.app/publication/magea3-stat1-tumor-microenvironment/Thu, 01 Nov 2018 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magea3-stat1-tumor-microenvironment/Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cellshttps://playful-bavarois-78840e.netlify.app/publication/magec2-trim28-posttranscriptional-regulation/Mon, 01 Oct 2018 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-trim28-posttranscriptional-regulation/Autophagy and Hallmarks of Cancerhttps://playful-bavarois-78840e.netlify.app/publication/autophagy-hallmarks-cancer/Mon, 01 Jan 2018 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/autophagy-hallmarks-cancer/Cancer-testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cellshttps://playful-bavarois-78840e.netlify.app/publication/magec2-taf9-cancer-cells/Fri, 01 Dec 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-taf9-cancer-cells/MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastomahttps://playful-bavarois-78840e.netlify.app/publication/mst4-atg4b-glioblastoma/Fri, 01 Dec 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/mst4-atg4b-glioblastoma/Extracellular matrix protein Reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysishttps://playful-bavarois-78840e.netlify.app/publication/reelin-myeloma-progression/Wed, 01 Mar 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/reelin-myeloma-progression/The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signalinghttps://playful-bavarois-78840e.netlify.app/publication/magec2-stat3-amoeboid-invasion/Wed, 01 Mar 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-stat3-amoeboid-invasion/Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cellshttps://playful-bavarois-78840e.netlify.app/publication/magec2-knockout-cancer-cells/Fri, 25 Nov 2016 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-knockout-cancer-cells/Thymic DCs derived IL-27 regulates the final maturation of CD4+ SP thymocyteshttps://playful-bavarois-78840e.netlify.app/publication/thymic-dc-il27-cd4-maturation/Fri, 29 Jul 2016 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/thymic-dc-il27-cd4-maturation/MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2https://playful-bavarois-78840e.netlify.app/publication/mir874-magec2-tumor-suppressor/Tue, 01 Mar 2016 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/mir874-magec2-tumor-suppressor/Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinomahttps://playful-bavarois-78840e.netlify.app/publication/kif23-hepatocellular-carcinoma/Wed, 16 Dec 2015 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/kif23-hepatocellular-carcinoma/Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin Ehttps://playful-bavarois-78840e.netlify.app/publication/magec2-rbx1-cyclin-e/Tue, 01 Dec 2015 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-rbx1-cyclin-e/Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulationhttps://playful-bavarois-78840e.netlify.app/publication/id1-treg-differentiation-tcr-costimulation/Tue, 15 Jul 2014 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/id1-treg-differentiation-tcr-costimulation/Id1 expression promotes peripheral CD4+ T cell proliferation and survival upon TCR activation without co-stimulationhttps://playful-bavarois-78840e.netlify.app/publication/id1-peripheral-cd4-tcell-survival/Sat, 15 Jun 2013 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/id1-peripheral-cd4-tcell-survival/Homeostatic Properties and Phenotypic Maturation of Murine CD4+ Pre-Thymic Emigrants in the Thymushttps://playful-bavarois-78840e.netlify.app/publication/cd4-prethymic-emigrants-thymus/Wed, 06 Feb 2013 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/cd4-prethymic-emigrants-thymus/Cancer-testis antigen HCA587-derived long peptide vaccine generates potent immunologic responses and antitumor effects in mouse modelhttps://playful-bavarois-78840e.netlify.app/publication/magec2-long-peptide-vaccine/Tue, 01 Jan 2013 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-long-peptide-vaccine/Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunityhttps://playful-bavarois-78840e.netlify.app/publication/curcumin-ctl-antitumor-immunity/Fri, 01 Apr 2011 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/curcumin-ctl-antitumor-immunity/